Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension



Status:Completed
Conditions:High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:11/19/2016
Start Date:September 2006
End Date:September 2007

Use our guide to learn which trials are right for you!

A Multiple-Dose Study of the IOP-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% When Added to a PGA as Adjunctive Therapy Over a 24 Hour Period in Patients With Glaucoma or Ocular Hypertension

This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0%
compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy
over a 24 hour period in patients with glaucoma or ocular hypertension.


Inclusion Criteria:

- Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

- Women of childbearing potential

- History of bronchial asthma, or severe chronic obstructive pulmonary disease

- Presence of acute glaucoma
We found this trial at
1
site
?
mi
from
San Diego, CA
Click here to add this to my saved trials